Yayınlanmış 1 Ocak 2020
| Sürüm v1
Dergi makalesi
Açık
Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study
Oluşturanlar
- 1. Hacettepe Univ, Dept Pediat Neurol, Ankara, Turkey
- 2. Marmara Univ, Fac Pharm, Istanbul, Turkey
- 3. Analyt Chem, Istanbul, Turkey
- 4. Marmara Univ, Sch Appl Disciplines, Istanbul, Turkey
- 5. Hacettepe Univ, Dept Radiol, Ankara, Turkey
Açıklama
Background: Aprepitant is a neurokinin-1 receptor antagonist approved for the treatment of chemotherapy-induced nausea. We aimed to investigate the safety and efficacy of aprepitant in patients with subacute sclerosing panencephalitis.
Dosyalar
bib-da6c7153-8111-41c9-ad5b-cb4872136539.txt
Dosyalar
(285 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:02d467fff9213f55ccc884020ec31f26
|
285 Bytes | Ön İzleme İndir |